contractpharmaMarch 12, 2019
Tag: patients , Chief Executive Officer , MARKET ACCESS
La Jolla Pharmaceutical Company announced the appointment of Darryl Wellinghoff as chief commercial officer.
"We are excited to welcome Darryl to La Jolla’s leadership team," said George Tidmarsh, M.D., Ph.D., La Jolla’s president and chief executive officer. "Darryl brings extensive and highly relevant experience and depth of knowledge in sales, marketing, product launch and market access gained as a result of many successful product launches. He no doubt will help us continue fulfilling our mission of providing potentially life-saving therapies to patients in need."
"La Jolla is developing life-saving products in areas of medicine that have had little innovation for decades, GIAPREZA is a great example of that. We have an incredible opportunity with GIAPREZA to impact the lives of patients and support our physician and hospital partners to deliver better outcomes for these complex patients," said Mr. Wellinghoff. "I look forward to working with the team to execute a commercial strategy that drives results and fulfills the life-saving mission of the company."
Prior to joining La Jolla, Mr. Wellinghoff spent 19 years in roles of increasing responsibility in the pharmaceutical industry including 15 years at The Medicines Company where he was the senior vice president - Americas, leading the commercial organization through multiple hospital-based product launches in Cardiovascular, Surgical, and Infectious Disease.
Register as Visitor to CPhI China 2019!
-----------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: